Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Brain derived neurotrophic factor in multiple sclerosis: effect of 24 weeks endurance and resistance training.
Oxidative stress and antioxidants in neurological diseases: is there still hope?
Author response.
Further evidence for the neuroprotective role of oleanolic acid in a model of focal brain hypoxia in rats.
MicroRNA in neurodegenerative drug discovery: the way forward?
A critical appraisal of daclizumab use as emerging therapy in multiple sclerosis.
Treatment of acute relapses in neuromyelitis optica: Steroids alone versus steroids plus plasma exchange.
Network collapse and cognitive impairment in multiple sclerosis.
Pushing the boundaries of neuromyelitis optica: Does antibody make the disease?
The utility of multimodal evoked potentials in multiple sclerosis prognostication.
Local dynamic stability as a responsive index for the evaluation of rehabilitation effect on fall risk in patients with multiple sclerosis: a longitudinal study.
Neurogenic detrusor overactivity is associated with decreased expression and function of the large conductance voltage- and ca(2+)-activated k(+) channels.
A Further TWEAK to Multiple Sclerosis Pathophysiology.
Present and emerging therapies for multiple sclerosis.
Therapeutic Apheresis in Pediatric Patients with Acute CNS Inflammatory Demyelinating Disease.
Stress in Multiple Sclerosis: Review of New Developments and Future Directions.
Neuromuscular manifestations of west nile virus infection.
HU-446 and HU-465, derivatives of the non-psychoactive cannabinoid cannabidiol, decrease the activation of encephalitogenic T cells.
Abnormal distribution of AQP5 in labial salivary glands is associated with poor saliva secretion in patients with Sjögren's syndrome including neuromyelitis optica complicated patients.
Sexual dimorphism in the aged rat CD4+ T lymphocyte-mediated immune response elicited by inoculation with spinal cord homogenate.
Equivalence of Glatiramer Acetate Generics With Branded Glatiramer Acetate in Efficacy and Cost for the Treatment of Multiple Sclerosis.
Multiple sclerosis: Daclizumab HYP shows superiority to IFN-β1a for reducing relapses in multiple sclerosis.
The molecular physiology of the axo-myelinic synapse.
Neuroprotection and immunomodulation by xenografted human mesenchymal stem cells following spinal cord ventral root avulsion.
Are There Differences in the Prevalence of Palliative Care-Related Problems in People Living With Advanced Cancer and Eight Non-Cancer Conditions? A Systematic Review.

Pages